Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California. Show more

4370 La Jolla Village Drive, San Diego, CA, 92122, United States

Biotechnology

Healthcare

Market Cap

117.7M

52 Wk Range

$3.35 - $17.94

Previous Close

$5.38

Open

$5.33

Volume

38,445

Day Range

$5.10 - $5.71

Enterprise Value

52.43M

Cash

73.87M

Avg Qtr Burn

-17.6M

Insider Ownership

16.12%

Institutional Own.

52.60%

Qtr Updated

06/30/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ARD-101 Details Prader-Willi Syndrome	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ARD-201 (DPP-4 Combination) Details Obesity	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.